Most compounded formulations need refrigeration between uses but should be warmed briefly before injection
For context, NICE guidance on existing approved GLP-1 receptor agonists for example, NICE TA875 (Semaglutide for managing overweight and obesity, 2023) acknowledges GI side effects as a recognised class effect and supports gradual dose escalation to improve tolerability
Semaglutide has been shown to reduce the risk of major cardiovascular events in individuals with type 2 diabetes
Better metabolic health does not automatically mean stronger tissues
A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy
Our study may indicate that medication such as Wegovy could have a dual effect both through weight loss and by increasing GLP-1 levels in the joints, Kragstrup said